PERCEPTIVE ADVISORS LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001224962
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 101 positions · Total reported value $5.20B · Top-10 concentration 53.5% · Updated 2026-11-17
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
Turnover: 65.6% · 18 new · 40 cut · 24 exited
Active Share (vs S&P 500): 99.3% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -8.8% · vs SPY -10.9% · Prev Value $6.30B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -1.6% · vs SPY -3.7% · Latest Value $5.20B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2026 13F filing, PERCEPTIVE ADVISORS LLC disclosed 101 equity positions with a combined reported value of $5.20B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 53.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were PRAX ($589.68M), SYRE ($309.04M), AMLX ($307.70M). By sector, the heaviest allocations are Health Care 94.4%, Industrials 1.8%. Versus the prior quarter, allocation shifted toward Health Care (+5.5pp), Industrials (+0.6pp) and away from Other (-5.9pp).
Versus the prior quarter, PERCEPTIVE ADVISORS LLC opened 18 new positions, trimmed 40 and fully exited 24, a turnover rate of 65.6% of positions. The portfolio's overlap with the prior quarter was 66% of names.
The largest new positions opened in Q3 2026 were WAT ($59.32M), IRD ($43.56M), LKFT ($36.84M).
Of the 24 positions fully exited versus the prior quarter, the largest were NUVL ($195.19M), APGE ($173.63M), IONS ($44.88M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
Fully Exited (vs previous quarter)
- NUVL NUVALENT INC · prev qtr: $195.19M
- APGE APOGEE THERAPEUTICS INC · prev qtr: $173.63M
- IONS IONIS PHARMACEUTICALS INC · prev qtr: $44.88M
- JAZZ JAZZ PHARMACEUTICALS PLC · prev qtr: $40.96M
- SION SIONNA THERAPEUTICS INC · prev qtr: $39.81M
- CORT CORCEPT THERAPEUTICS INC · prev qtr: $34.64M
- CRL CHARLES RIV LABS INTL INC · prev qtr: $31.75M
- AXSM AXSOME THERAPEUTICS INC. · prev qtr: $28.99M
Insider Transactions (Form 4)
Latest PERCEPTIVE ADVISORS LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-10-26 | Opt exercise | LeonaBio, Inc. | 776,648 | $0.00 | SEC filing |
| 2026-08-26 | Buy | Immatics N.V. | 863,060 | $8.69 | SEC filing |
| 2026-07-20 | Award | Freenome, Inc. | 5,500,000 | $10.00 | SEC filing |
| 2026-06-17 | Award | Kardigan, Inc. | 20,706 | — | SEC filing |
| 2026-04-17 | Award | MeiraGTx Holdings plc | 555,555 | $9.00 | SEC filing |
Fund Profile
Perceptive Advisors is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 101 US equity positions with a combined value of $5.20B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-71841 (status: Approved), registered 2010-10-04
- Regulatory AUM (Form ADV): $11.77B as of 2026-07-13
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 17 private funds, of which 6 hedge funds
Portfolio Structure
- 101 positions · $5.20B reported value (Q3 2026)
- Top 10 holdings = 53.5% of reported value
- Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 11.3%
- Average position size: $51.53M
Sector Tilt
- Health Care 94.4%
- Industrials 1.8%
- Financials 0.0%
- (classified holdings cover 96% of value)
Quarterly Activity
- Q3 2026: 18 new, 15 added, 40 reduced, 24 exited
- 28 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 09:40
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
2.02M | $589.68M | 11.33% | Reduce | |
| 2 |
|
4.20M | $309.04M | 5.94% | Reduce | |
| 3 |
|
10.57M | $307.70M | 5.91% | Add | |
| 4 |
|
1.40M | $269.60M | 5.18% | Add | |
| 5 |
|
2.53M | $241.14M | 4.63% | Reduce | |
| 6 |
|
6.51M | $238.11M | 4.58% | Reduce | |
| 7 |
|
12.73M | $229.78M | 4.42% | Reduce | |
| 8 |
|
971.52K | $221.34M | 4.25% | Reduce | |
| 9 |
|
3.54M | $208.61M | 4.01% | Reduce | |
| 10 |
|
4.14M | $168.01M | 3.23% | Reduce | |
| 11 |
|
1.29M | $129.35M | 2.48% | Hold | |
| 12 |
|
5.37M | $127.36M | 2.45% | Add | |
| 13 |
|
8.20M | $120.96M | 2.32% | Hold | |
| 14 |
|
10.79M | $118.65M | 2.28% | Hold | |
| 15 |
|
836.58K | $117.87M | 2.27% | Reduce | |
| 16 |
|
11.25M | $98.74M | 1.90% | Add | |
| 17 |
|
3.55M | $93.92M | 1.80% | Reduce | |
| 18 |
|
1.07M | $89.32M | 1.72% | Reduce | |
| 19 |
|
433.10K | $88.90M | 1.71% | Reduce | |
| 20 |
|
11.91M | $86.09M | 1.65% | Hold | |
| 21 |
|
10.30M | $85.81M | 1.65% | Hold | |
| 22 |
|
2.68M | $76.22M | 1.47% | Hold | |
| 23 |
|
2.69M | $67.19M | 1.29% | Reduce | |
| 24 |
|
135.00K | $59.32M | 1.14% | New | |
| 25 |
|
272.46K | $52.37M | 1.01% | Add | |
| 26 |
|
2.11M | $48.20M | 0.93% | Add | |
| 27 |
|
1.76M | $44.96M | 0.86% | Add | |
| 28 |
|
9.00M | $43.56M | 0.84% | New | |
| 29 |
|
1.24M | $36.84M | 0.71% | New | |
| 30 |
|
345.23K | $34.12M | 0.66% | New | |
| 31 |
|
200.00K | $31.54M | 0.61% | Reduce | |
| 32 |
|
5.04M | $31.33M | 0.60% | Hold | |
| 33 |
|
2.50M | $30.77M | 0.59% | Add | |
| 34 |
|
2.51M | $28.92M | 0.56% | Reduce | |
| 35 |
|
3.43M | $26.62M | 0.51% | Hold | |
| 36 |
|
1.66M | $26.57M | 0.51% | Reduce | |
| 37 |
|
1.32M | $25.70M | 0.49% | New | |
| 38 |
|
9.27M | $25.21M | 0.48% | Reduce | |
| 39 |
|
724.34K | $24.34M | 0.47% | Reduce | |
| 40 |
|
567.48K | $22.21M | 0.43% | New | |
| 41 |
|
7.35M | $21.32M | 0.41% | Reduce | |
| 42 |
|
462.51K | $21.20M | 0.41% | New | |
| 43 |
|
6.63M | $21.01M | 0.40% | Hold | |
| 44 |
|
1.27M | $20.38M | 0.39% | Reduce | |
| 45 |
|
2.46M | $19.67M | 0.38% | Hold | |
| 46 |
|
813.10K | $18.31M | 0.35% | New | |
| 47 |
|
519.35K | $17.54M | 0.34% | Reduce | |
| 48 |
|
11.56M | $16.42M | 0.32% | Reduce | |
| 49 |
|
970.85K | $15.64M | 0.30% | Reduce | |
| 50 |
|
600.00K | $14.59M | 0.28% | Add | |
FAQ
What did PERCEPTIVE ADVISORS LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, PERCEPTIVE ADVISORS LLC reported 101 equity positions worth $5.20B in aggregate; its largest disclosed positions were PRAX ($589.68M), SYRE ($309.04M), AMLX ($307.70M).
How large is PERCEPTIVE ADVISORS LLC's portfolio?
PERCEPTIVE ADVISORS LLC reported $5.20B of long equity holdings across 101 positions as of 2026-Q3. Top-10 holdings account for 53.5% of reported value.
What is PERCEPTIVE ADVISORS LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.